[1]
2022. Pharmaceutical care directed to patients with rheumatoid arthritis and systemic lupus erythematosus: survey of a pharmacotherapeutic profile. Research, Society and Development. 11, 16 (Dec. 2022), e203111638026. DOI:https://doi.org/10.33448/rsd-v11i16.38026.